36
Participants
Start Date
March 31, 2007
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
Intravenous diclofenac sodium (DIC075V) 18.75 mg
DIC075V 18.75 mg
Intravenous diclofenac sodium (DIC075V) 37.5 mg
DIC075V 37.5 mg
Oral diclofenac potassium 50 mg
Oral diclofenac potassium 50 mg
PAREXEL International, Baltimore
Lead Sponsor
Javelin Pharmaceuticals
INDUSTRY